A different way to relieve sleeplessness and support healthy mood
Clinically researched to support healthy mood balance and relieve stress, restlessness and mild anxiety4-6
Clinically researched to help falling asleep faster, reduce night time waking and improve healthy sleep patterns1-3
✓ Clinically researched herbal extract of St John’s wort Ze 117
✓ Clinically researched herbal extract combination of hops and valerian Ze 91019
✓ Low hyperforin content, for the reduced risk of drug interactions
✓ Non addictive extract that does not leave a sedated feeling the next day
To discover the Flordis integrative medicine pharmacy specials, contact your Flordis representative: www.flordis.com.au or by contacting customer service on 1800 334 224. These medicines may not be right for you. Read the label before purchase. Follow the directions for use. If symptoms persist, talk to your health professional. REFERENCES: 1. Koetter U, et al. A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytother Res 2007;21(9):847-51. 2. Füssel A, et al. Effect of a fixed valerian-hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res. 2000;5:385–90. 3. Notter D, et al. Efficacy and safety of a valerian-hops combination-preparation in different sleep disorders, a therapy observation. Phytotherapy. 2003;3:9-13. 4. Brattstrom A. Long-term effects of St. John’s wort (Hypericum perforatum) treatment. Phytomedicine 2009;16:277-83. 5. Schrader E Equivalence of St John’s wort extract (Ze 117) and fluoxetine. Int Clin Psychopharmacol. 2000;15:61-8. 6. Schrader E, et al. Hypericum treatment in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Hum Psychopharmacol 1998; 13(3):163–9.
Avai lab Now le
Features that are SMARTER
AID - Drug Directions
Mon 2nd August 2021
Today’s issue of PD Pharmacy Daily today features two pages of news, plus a front cover page from Flordis, a fact sheet from CHP Australia and a full page from Essity.
Sleep easy WHEN life gets stressful it can be difficult to unwind and find sleep. However, natural supplement brand, Flordis’s Remotiv and ReDormin Forte products aim to help patients combat stress and anxiety, and to find sleep a little easier. See today’s cover page for more.
FRED.COM.AU
Please look after yourselves: Board PHARMACISTS are being urged to pay attention to their health and wellbeing, amid growing cases of substance abuse within the profession. The issue was raised by Pharmacy Board of Australia Chair, Brett Simmonds, during the Pharmaceutical Society of Australia’s (PSA’s) national conference at the weekend. “We are seeing a significant number of health issues around pharmacists, particularly from substance abuses and things like that, which could possibly result from the extra stress that everyone is under at this time,” he said. “I would really request that pharmacists please do not neglect themselves, their own physical and mental health and wellbeing at this time when we know everyone is under a lot of stress being on the frontline of this pandemic.” While flagging concerns around pharmacists’ wellbeing, Simmonds
noted that the number of notifications being made against members of the profession were “relatively stable - unlike some of the other health professions that are going up atw quite a rapid rate”. “There are a couple of things I would like to highlight,” he said. “Generally speaking labelling issues and minor dispensing issues are decreasing - probably because of the use of scanners and things like that that are happening now. “But we’re getting increasing numbers of [notifications about] poor communication-related behaviours around interactions with the public. “We’re also seeing an increase in dose administration aid (DAA) errors, which is mainly due to entering data, so can I just suggest to pharmacists who are supplying DAAs to really ensure that they check before they’re supplied to their patients.” While noting the issues facing
the profession, Simmonds praised pharmacists’ performances during the COVID-19 pandemic. “A large proportion are really performing to a high standard of practice,” he said. “There’s only a small number we see in terms of notifications, where their practice falls below the standards. “So I just want to highlight that everyone is doing a wonderful job and [I] applaud everyone for the work that you’re doing at the moment.”
World’s #1 pain relief brand.* Now in Australia.
*OTC pain relief value sales, Nicholas Hall Global CHC database, DB6 2019. †Based on two caplet dose. ^Qi DS et al. Clin Ther. 2012 Dec;34(12):2247-2258 (sponsored by Tylenol®). Always read the label. Follow the directions for use. If symptoms persist, talk to your health professional. Incorrect use could be harmful.
Pharmacy Daily
e info@pharmacydaily.com.au
t 1300 799 220
w www.pharmacydaily.com.au
page 1
AMH AGED CARE COMPANION IN BOOK OR ONLINE. ORDER NOW. To find out more go to www.amh.net.au
Mon 2nd August 2021
Dispensary Corner WE ALL know sugary soft drinks are bad for your health, but this is ridiculous. A US man has been taken to hospital for checks after shooting at his refrigerator because a soda can exploded. Officers said they responded to a scene on the weekend after reports of gunshots, arriving to find him lying on the ground outside his home “yelling incoherently”. Witnesses said the offender had been stocking his fridge with the cans when one of them popped, causing him to respond by pulling a pistol out of his waistband and firing a round into the bottom of the fridge. He told investigators that “the people who live in the basement want to kill me” so he was firing in self-defense. However detectives advised that in fact there was no basement under the building at all, making it difficult for attacks to come from that angle. The man was charged with unlawful possession of a gun.
Corum restructures team PHARMACY software specialist Corum Group Limited has appointed James Nevile as its new Chief Operating Officer, as part of changes to “build a more effective and appropriate structure for future growth”. Nevile, who is a pharmacist by training, joins Corum from Fred IT where he oversaw the firm’s e-prescribing rollout, while other appointments at the company include Eric Moschietto-Fransa who is leading the PharmX sales team. Moschietto-Fransa joins Corum with extensive industry experience including roles with L’Oreal and PZ Cussons. Zoe Hillier has also been promoted to Chief Financial Officer. Redundancy costs associated with the restructure amounted to $434,000 during the last quarter, which also saw some “customer churn” after Corum discontinued one of its legacy dispensing products, Amfac. An investor update noted the ongoing development of Corum Clear Suite which was showcased at APP2021 in May, in a series of interactive demonstrations with groups and pharmacy owners which were “well received and
offered an opportunity to gain further customer insights and importantly, a number of new business opportunities,” the company said. Five new integration partners were added to the PharmX gateway during the quarter which saw utilisation increase 2.8% “indicative of increasing awareness and adoption of the platform and its services by pharmacy”. Corum ended the quarter with a cash balance of $6.5 million, with operating cashflow up 38% quarter on quarter, excluding redundancies.
QUT’s Robinson claims PSotY 21 QUEENSLAND University of Technology’s (QUT’s) Zoe Robinson claimed the 2021 Pharmacy Student of the Year (PSotY) title at last weekend’s Pharmaceutical Society of Australia (PSA) national conference. University of South Australia’s Dharshan Rasiah, took out the People’s Choice award. PSA National President, Associate Professor Chris Freeman, noted the high quality of this year’s finalists. “It is heartening to see the future of our profession on show, demonstrating a high level of clinical knowledge, capability and passion – evidently, the future of pharmacy is incredibly bright,” he said. “I congratulate Zoe on her achievement and would like to thank all the finalists in what was a difficult decision for the judging panel.” Robinson has received a travel prize for pharmacy-specific education to the value of $5,000.
PBS lists chronic migraine treatment TEVA Pharma Australia’s Ajovy (fremanezumab) has been listed on the Pharmaceutical Benefits Scheme (PBS) from 01 Aug, for the prevention of chronic migraine. Ajovy is the first anti-calcitonin gene-related peptide (AntiCGRP) to be listed on the PBS that does not require patients to take a loading dose when commencing treatment.
www.pharmacydaily.com.au Pharmacy Daily is part of the Business Publishing Group family of publications. Pharmacy Daily is Australia’s favourite pharmacy industry publication.
Pharmacy Daily
EDITORIAL Editor in Chief and Publisher – Bruce Piper Editor – Nicholas O’Donoghue Contributors – Adam Bishop, Myles Stedman info@pharmacydaily.com.au
ADVERTISING AND MARKETING Sean Harrigan, Hoda Alzubaidi advertising@pharmacydaily.com.au BUSINESS MANAGER Jenny Piper accounts@pharmacydaily.com.au
To be eligible for reimbursement of Ajovy, patients must have experienced an average of 15 or more headache days per month, with at least eight days of migraine, over a period of six months prior to receiving treatment. Ajovy has been available in Australia since Sep 2019, and is available for episodic migraine under private prescriptions.
Suite 1, Level 2, 64 Talavera Rd Macquarie Park NSW 2113 Australia PO Box 1010 Epping NSW 1710 Australia Tel: 1300 799 220 (+61 2 8007 6760) Sign up free at www.pharmacydaily.com.au
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
e info@pharmacydaily.com.au
t 1300 799 220
w www.pharmacydaily.com.au
business events news
page 2
FACT SHEET CHP AUSTRALIA www.pharmacydaily.com.au Mon 2nd August 2021
e info@pharmacydaily.com.au
t 1300 799 220
w www.pharmacydaily.com.au
ProShield
®
N-95 RESPIRATOR ProShield N-95 Respirators are designed to: • Closely fit the shape of your face so that contaminated air is restricted from being breathed in via gaps between the sides of the respirator and your face • Provide a higher level of protection than a standard mask • Feature head bands so that the respirator is held close against the face
Description
Items per unit
Min Order
API
CH2
Sigma
Symbion
72509-25 ProShield® N-95 Small
bx/30
3
325724
2526031
899716
557714
72509-26 ProShield® N-95 Medium
bx/30
3
325732
2521432
899724
557889
Ref-no.
ProShield® meets Australian and New Zealand Standards
Purchase 3 boxes of ProShield N-95 and receive 30% off For more information, please contact your local Essity Representative or customer service on 1300 998 810.
QTY
AS/NZS 4381:2015 Single-use face ProShield masks for use in Protector healthcare
✓
AS/NZS 1716:2012 Respiratory Protective Devices
Proshield N-95
✓
Email all orders to pharmacy.anz@essity.com Contact name Address Email
Telephone
Offer valid until 31 August 2021 PO Box 337, Mount Waverley, Victoria, Australia 3149 ESS0399
07/2021
www.essity.com
Customer Service Australia T 1300 276 633 F 1300 998 830 Customer Service New Zealand T 0508 276 111 F 0508 998 830